| ASSET | MONTH | % RETURN |
|---|---|---|
Coda Octopus (CODA) | March 2012 | 1,580% |
QXO (QXO) | March 2012 | 710.81% |
OptimumBank (OPHC) | March 2012 | 357.2% |
Quest Resource (QRHC) | March 2012 | 266.67% |
Recon Technology (RCON) | March 2012 | 211.23% |
Kaival Brands Innovations (KAVL) | March 2012 | 150% |
Netcapital (NCPL) | March 2012 | 133.33% |
Agenus (AGEN) | March 2012 | 118.38% |
Sellas Life Sciences (SLS) | March 2012 | 101.81% |
Supercom (SPCB) | March 2012 | 100% |
Patrick Industries (PATK) | March 2012 | 97.24% |
POET Technologies (POET) | March 2012 | 95.83% |
Zivo Bioscience (ZIVO) | March 2012 | 91.95% |
Intellicheck Mobilisa (IDN) | March 2012 | 91.36% |
Lifevantage (LFVN) | March 2012 | 87.07% |
XOMA (XOMA) | March 2012 | 82.24% |
BioRestorative Therapies (BRTX) | March 2012 | 75% |
Cocrystal Pharma (COCP) | March 2012 | 71.71% |
Castellum (CTM) | March 2012 | 71.43% |
Empire Petroleum (EP) | March 2012 | 70.01% |
Cellectar Biosciences (CLRB) | March 2012 | 70% |
Ontrak (OTRK) | March 2012 | 66.67% |
Celsius (CELH) | March 2012 | 66.63% |
Harrow Health (HROW) | March 2012 | 60.71% |
Avalon (AWX) | March 2012 | 53.42% |
